D-0868-2017 Class III Terminated

Recalled by Sandoz Inc — Princeton, NJ

FDA drug recall D-0868-2017 was initiated by Sandoz Inc on Apr 26, 2017 and is designated Class III. Reason for recall: Subpotent Drug; Clavulanic Acid The recall status is terminated (terminated Aug 19, 2019). Affected quantity: 4,464 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 7, 2017
Initiation Date
Apr 26, 2017
Termination Date
Aug 19, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,464 bottles

Product description

Amoxicillin and Clavulanate Potassium Tablets, USP, 500 mg/125 mg, in 20 count bottles, Rx Only, Manufactured in Austria by Sandoz Gmbh for Sandoz Inc. Princeton NJ NDC 0781-1831-20

Reason for recall

Subpotent Drug; Clavulanic Acid

Distribution pattern

NY, OH

Code information

Lot FP8735, 8/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0868-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0868-2017. Report a data issue: hello@regdatalab.com.